Will 2016 Be The Year of the Biosimilar?
This article was originally published in RPM Report
Executive Summary
The first wave of biosimilars seemed ready to come to market in 2015, but only one product actually made it through FDA. The coming year might be the year when multiple biosimilars enter the US.